Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew F Shorr

Showing results (161-170 of 322) with videos related to

Pageof 33
Sort By:
Current Medical Research and Opinion|March 12, 2008
Anemia in chronic obstructive pulmonary disease: epidemiology and economic implicationsAndrew F Shorr, John Doyle, Lee Stern, et al.
Chest|July 22, 2008
Prevention of venous thromboembolism in neurosurgery: a metaanalysisJacob F Collen, Jeffrey L Jackson, Andrew F Shorr, et al.
Chest|May 17, 2007
Analyzing the short-term effect of placebo therapy in pulmonary arterial hypertension: potential implications for the design of future clinical trialsDonald L Helman, Alexander W Brown, Jeffrey L Jackson, et al.
Journal of Thrombosis and Thrombolysis|November 30, 2006
Minimizing costs for treating deep vein thrombosis: the role for fondaparinuxAndrew F Shorr, William L Jackson, Lisa K Moores, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United StatesKeith S Kaye, Lindsay A Petty, Andrew F Shorr, et al.
Infection Control and Hospital Epidemiology|February 20, 2015
Clostridium difficile recurrence is a strong predictor of 30-day rehospitalization among patients in intensive careMarya D Zilberberg, Andrew F Shorr, Scott T Micek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2021
Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant Staphylococcus aureus Infections?-NoSarah C J Jorgensen, Brad Spellberg, Andrew F Shorr, et al.
Infection Control and Hospital Epidemiology|March 24, 2022
Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, et al.
Journal of Hospital Medicine|July 21, 2015
Risk factors for 30-day readmission among patients with culture-positive severe sepsis and septic shock: A retrospective cohort studyMarya D Zilberberg, Andrew F Shorr, Scott T Micek, et al.
Chest|March 10, 2004
Sarcoidosis, race, and short-term outcomes following lung transplantationAndrew F Shorr, Donald L Helman, Darcy B Davies, et al.
Pageof 33

Showing results (161-170 of 322) with videos related to

Sort By:
Pageof 33
Current Medical Research and Opinion|March 12, 2008
Anemia in chronic obstructive pulmonary disease: epidemiology and economic implicationsAndrew F Shorr, John Doyle, Lee Stern, et al.
Chest|July 22, 2008
Prevention of venous thromboembolism in neurosurgery: a metaanalysisJacob F Collen, Jeffrey L Jackson, Andrew F Shorr, et al.
Chest|May 17, 2007
Analyzing the short-term effect of placebo therapy in pulmonary arterial hypertension: potential implications for the design of future clinical trialsDonald L Helman, Alexander W Brown, Jeffrey L Jackson, et al.
Journal of Thrombosis and Thrombolysis|November 30, 2006
Minimizing costs for treating deep vein thrombosis: the role for fondaparinuxAndrew F Shorr, William L Jackson, Lisa K Moores, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United StatesKeith S Kaye, Lindsay A Petty, Andrew F Shorr, et al.
Infection Control and Hospital Epidemiology|February 20, 2015
Clostridium difficile recurrence is a strong predictor of 30-day rehospitalization among patients in intensive careMarya D Zilberberg, Andrew F Shorr, Scott T Micek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2021
Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant Staphylococcus aureus Infections?-NoSarah C J Jorgensen, Brad Spellberg, Andrew F Shorr, et al.
Infection Control and Hospital Epidemiology|March 24, 2022
Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, et al.
Journal of Hospital Medicine|July 21, 2015
Risk factors for 30-day readmission among patients with culture-positive severe sepsis and septic shock: A retrospective cohort studyMarya D Zilberberg, Andrew F Shorr, Scott T Micek, et al.
Chest|March 10, 2004
Sarcoidosis, race, and short-term outcomes following lung transplantationAndrew F Shorr, Donald L Helman, Darcy B Davies, et al.
Pageof 33